Li Y, Qin J J, Wang Z, Yu Y, Wen Y Y, Chen X K, Liu W X, Li Y
Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Department of Thoracic Surgery, Cancer Hospital of Huanxing, ChaoYang District, Beijing 100022, China.
Zhonghua Zhong Liu Za Zhi. 2020 Apr 23;42(4):296-300. doi: 10.3760/cma.j.cn112152-20200226-00128.
Since December 2019, unexplained pneumonia has appeared in Wuhan City, Hubei Province, and a new type of coronavirus infection was confirmed as COVID-19. COVID-19 spread rapidly nationwide and abroad. The COVID-19 has brought huge impacts to all the people and walks of life, especially to the medical and health systems. It has also brought great challenges to the treatment of patients with cancer. Esophageal cancer is a common malignant tumor in China and most of the patients are in the middle and advanced stage when diagnosed, with immunosuppressive and poor prognosis. The selection of surgical procedures and perioperative managements of esophageal cancer require all thoracic surgeons work together to figure out a reasonable system of surgical treatment and emergency response.
自2019年12月以来，湖北省武汉市出现不明原因肺炎，一种新型冠状病毒感染被确认为COVID-19。COVID-19在国内外迅速传播。COVID-19给全体人民和各行各业带来了巨大影响，尤其是对医疗卫生系统。它也给癌症患者的治疗带来了巨大挑战。食管癌是我国常见的恶性肿瘤，大多数患者确诊时已处于中晚期，免疫功能低下，预后较差。食管癌手术方式的选择和围手术期管理需要全体胸外科医生共同努力，制定合理的手术治疗和应急反应体系。
